Elevance Health (NYSE:ELV) reported quarterly earnings of $12.58 per share which beat the analyst consensus estimate of $10.79 by 16.59 percent. This is a 5.1 percent increase over earnings of $11.97 per share from the same period last year. The company reported quarterly sales of $49.494 billion which beat the analyst consensus estimate of $48.335 billion by 2.40 percent. This is a 1.49 percent increase over sales of $48.765 billion the same period last year.